Early intermediates in the biosynthesis of ansamycins. II. Isolation and identification of proasamycin B-M1 and protorifamycin I-M1.

  • GHISALBA ORESTE
    Pharmaceuticals Division and Central Function Research of CIBA-GEIGY Limited
  • TRAXLER PETER
    Pharmaceuticals Division and Central Function Research of CIBA-GEIGY Limited
  • FUHRER HERMANN
    Pharmaceuticals Division and Central Function Research of CIBA-GEIGY Limited
  • RICHTER WILHELM J.
    Pharmaceuticals Division and Central Function Research of CIBA-GEIGY Limited

Bibliographic Information

Other Title
  • II. ISOLATION AND IDENTIFICATION OF PROANSAMYCIN B-M1 AND PROTORIFAMYCIN I-M1

Search this article

Description

Proansamycin B-M1 and protorifamycin I-M1 were isolated as minor compounds from fermentations of the protorifamycin I producing strain Nocardia mediterranei F 1/241), identified by means of chemical and spectroscopic methods and shown to be degradation products of the hypothetical proansamycin B postulated in part I of this series of papers1) and of protorifamycin I, respectively.

Journal

Citations (1)*help

See more

Details 詳細情報について

  • CRID
    1390001204153662720
  • NII Article ID
    130003409046
  • DOI
    10.7164/antibiotics.32.1267
  • COI
    1:CAS:528:DyaL3cXht1Cmt74%3D
  • ISSN
    18811469
    00218820
  • PubMed
    396289
  • Text Lang
    en
  • Article Type
    journal article
  • Data Source
    • JaLC
    • Crossref
    • PubMed
    • CiNii Articles
  • Abstract License Flag
    Disallowed

Report a problem

Back to top